Document Detail


Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
MedLine Citation:
PMID:  1976298     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A double-blind clinical trial of 51 patients with chronic idiopathic urticaria using oral astemizole for 8 weeks demonstrated significant improvement in symptoms and lesions in 75% of treated patients versus 20% in the placebo group. The suppression of urticaria persisted for an average of 38 days, demonstrating the long duration of action of astemizole.
Authors:
R W Honsinger; R J Thomsen
Related Documents :
10826458 - Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory dru...
7772628 - Reduction of postoperative immunosuppression with ranitidine in patients with cancer of...
12610178 - Phase iii comparison of two irinotecan dosing regimens in second-line therapy of metast...
7779648 - The effect of ranitidine on symptom relief and quality of life of patients with gastro-...
8861598 - Osteoarthrosis following the putti-platt operation.
3180298 - Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, l...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of allergy     Volume:  65     ISSN:  0003-4738     ISO Abbreviation:  Ann Allergy     Publication Date:  1990 Sep 
Date Detail:
Created Date:  1990-10-19     Completed Date:  1990-10-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372346     Medline TA:  Ann Allergy     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  194-200     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of New Mexico School of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Astemizole
Benzimidazoles / adverse effects,  therapeutic use*
Chronic Disease
Clinical Trials as Topic
Double-Blind Method
Histamine H1 Antagonists / therapeutic use
Humans
Time Factors
Urticaria / drug therapy*,  pathology
Chemical
Reg. No./Substance:
0/Benzimidazoles; 0/Histamine H1 Antagonists; 68844-77-9/Astemizole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adjusting the loading dose of magnesium sulfate for tocolysis.
Next Document:  Restriction enzyme analysis of mitochondrial DNA of the Aspergillus flavus group: A. flavus, A. para...